Antibioterapia inhalada en otras enfermedades respiratorias

Keyphrases

• Respiratory Disease 100%
• Antimicrobial 100%
• Antibiotic Therapy 100%
• Inhaled Antibiotics 100%
• Aerosolized 100%
• Cystic Fibrosis 66%
• Infection Site 66%
• Clinical Practice 33%
• Route of Administration 33%
• Absence of Evidence 33%
• High Concentration 33%
• Chronic Obstructive Pulmonary Disease 33%
• Lung 33%
• Bronchiectasis 33%
• Aerosol 33%
• Maintenance Treatment 33%
• Gaps in Knowledge 33%
• Pneumocystis Jirovecii 33%
• Fungal Respiratory Infections 33%
• Lung Infection 33%
• Ventilator-associated Pneumonia 33%
• Non-cystic Fibrosis Bronchiectasis 33%
• Systemic Toxicity 33%
• Antibiotic Administration 33%
• Aerosolized Antibiotics 33%

Medicine and Dentistry

• Infection 100%
• Antibiotic Therapy 100%
• Bronchiectasis 100%
• Respiratory Disease 100%
• Patient with Cystic Fibrosis 100%
• Diseases 50%
• Lung 50%
• Chronic Obstructive Pulmonary Disease 50%
• Fibrosis 50%
• Antibiotics 50%
• Antiinfective Agent 50%
• Lung Infection 50%
• Maintenance Therapy 50%
• Pneumocystis Pneumonia 50%
• Ventilator-Associated Pneumonia 50%
• Pulmonary Fungal Infection 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Respiratory Tract Disease 100%
• Antibiotic Therapy 100%
• Bronchiectasis 100%
• Lung Infection 100%
• Cystic Fibrosis 100%
• Diseases 50%
• Chronic Obstructive Lung Disease 50%
• Fibrosis 50%
• Antibiotics 50%
• Antiinfective Agent 50%
• Route of Administration 50%
• Ventilator Associated Pneumonia 50%
• Pneumocystis Pneumonia 50%